LH Assay kit CLIA

Primary DI

06974521004233

Basic UDI-DI Code

B-06974521004233

Reference

SUPM060072

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This kit is used for in vitro quantitative detection of luteinizing hormone (LH) in human serum and (or) plasma. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) belong to gonadotrophins and they regulate and promote the growth and function of sexual glands (ovary and testis) collaboratively. Like FSH, thyroid stimulating hormone (TSH) and human Chorionic Gonadotropin (hCG), LH is a kind of glycoprotein that contains two subunits (α chain and β chain) and consists of 121 amino acids 2 and 3 carbohydrate chains and whose molecular mass is 29500 Dalton. Gonadotropin participates in regulating the circulation of hypothalamus-hypophysis-ovary to control women's menstrual cycle. Gonadotropic cells of adenohypophysis produce impulsion, which is transferred to ovary through blood circulation to generate LH and FSH. Gonadotropin stimulates the production, development and maturity of follicle and synthesizes estrogen and progesterone. In the middle of a physiological period, the LH concentration reaches the maximum and induces ovulation and the formation of corpus luteum (main secretion is progesterone). LH also can stimulate leydig cells to secret testicular hormone. LH concentration can be tested to indicate dysfunction of the hypothalamus-hypophysis-ovary system. LH and FSH can be tested jointly to give prompts of the following diseases: Congenital diseases caused by chromosomal aberration (such as Turner’s syndrome) and polycystic ovaries (PCO), and explain the reasons for such diseases as irregular menstruation, climacteric syndrome and leydig cell insufficiency.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).